NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001647

Registered date:20/01/2009

A prospective study of Trimethoprime-sulfamethoxazole(TMP/SMX) for prevention of Pneumocystis pneumonia(PCP) in patients under immunosuppressive therapy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedThe patients with rheumatic diseases who are receiving more than 30mg/day of prednisolone
Date of first enrollment2008/04/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Daily a week administration of a TMP/SMX(Bacter) tablet Twice a week administration of a TMP/SMX(Bacter) tablet

Outcome(s)

Primary OutcomeIncidence of PCP
Secondary Outcome1)Positive rate of Pneumocystis polymerase chain reaction in sputum 2)Incidence of the increased plasma level of beta-D-gulucan

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1.On TMP/SMX 2.Suffering from PCP 3.Complicated with serious liver and/or renal disfunction,cytopenia 4.Allergy to TMP/SMX 5.Pregnant,and/or nursing 6.In approppriate patients decided by doctors

Related Information

Contact

public contact
Name Shinichi Kwai
Address 6-11-1 Omori-Nishi, Ota-ku Tokyo 143-8541,Japan. Japan
Telephone 03-3762-4151(ext.6591)
E-mail skawai@med.toho-u.ac.jp
Affiliation Department of Internal Medicine, Toho University School of Mdicine, Tokyo,Japan Division of Rheumatology
scientific contact
Name Shinichi Kwai
Address 6-11-1 Omori-Nishi, Ota-ku Tokyo 143-8541,Japan Japan
Telephone 03-3762-4151(ext.6591)
E-mail
Affiliation Department of Internal Medicine, Toho University School of Mdicine Division of Rheumatology